Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician

Guy Hans1,2, Dominique Robert3, Johanna Verhulst2, Marcel Vercauteren1,21Department of Anesthesiology, 2Multidisciplinary Pain Center, 3Department of Intensive Care, Antwerp University Hospital, Edegem, BelgiumAbstract: Neuropathic pain (NeP) syndromes remain a difficult-to-treat medical entity. Des...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Guy Hans, Dominique Robert, Johanna Verhulst, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/20d456d711354677afaf1faa87794520
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:20d456d711354677afaf1faa87794520
record_format	dspace
spelling	oai:doaj.org-article:20d456d711354677afaf1faa877945202021-12-02T01:00:43ZLidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician1179-1438https://doaj.org/article/20d456d711354677afaf1faa877945202010-03-01T00:00:00Zhttp://www.dovepress.com/lidocaine-5-patch-for-localized-neuropathic-pain-progress-for-the-pati-a4160https://doaj.org/toc/1179-1438Guy Hans1,2, Dominique Robert3, Johanna Verhulst2, Marcel Vercauteren1,21Department of Anesthesiology, 2Multidisciplinary Pain Center, 3Department of Intensive Care, Antwerp University Hospital, Edegem, BelgiumAbstract: Neuropathic pain (NeP) syndromes remain a difficult-to-treat medical entity. Despite a growing number of pharmacological and invasive analgesic therapies the results remain less than optimal because of insufficient analgesic efficacy and/or occurrence of pronounced side effects. Current guidelines propose the use of multimodal and balanced pharmacological therapies, focused on the underlying pathophysiological mechanisms (mechanistic approach). Lidocaine 5% patches are a new treatment option currently licensed for the treatment of postherpetic neuralgia. However, these patches can also be used for the treatment of different types of superficial NeP syndromes, such as diabetic polyneuropathy. Their therapeutic success, however, largely depends on the correct identification of appropriate patients and pain syndromes. This manuscript outlines the correct identification of patients and proper use of these patches in order to ensure as much as possible the therapeutic efficacy of this new treatment option.Keywords: neuropathic pain, lidocaine, patch Guy HansDominique RobertJohanna Verhulstet alDove Medical PressarticleTherapeutics. PharmacologyRM1-950ENClinical Pharmacology: Advances and Applications, Vol 2010, Iss default, Pp 65-70 (2010)
institution	DOAJ
collection	DOAJ
language	EN
topic	Therapeutics. Pharmacology RM1-950
spellingShingle	Therapeutics. Pharmacology RM1-950 Guy Hans Dominique Robert Johanna Verhulst et al Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
description	Guy Hans1,2, Dominique Robert3, Johanna Verhulst2, Marcel Vercauteren1,21Department of Anesthesiology, 2Multidisciplinary Pain Center, 3Department of Intensive Care, Antwerp University Hospital, Edegem, BelgiumAbstract: Neuropathic pain (NeP) syndromes remain a difficult-to-treat medical entity. Despite a growing number of pharmacological and invasive analgesic therapies the results remain less than optimal because of insufficient analgesic efficacy and/or occurrence of pronounced side effects. Current guidelines propose the use of multimodal and balanced pharmacological therapies, focused on the underlying pathophysiological mechanisms (mechanistic approach). Lidocaine 5% patches are a new treatment option currently licensed for the treatment of postherpetic neuralgia. However, these patches can also be used for the treatment of different types of superficial NeP syndromes, such as diabetic polyneuropathy. Their therapeutic success, however, largely depends on the correct identification of appropriate patients and pain syndromes. This manuscript outlines the correct identification of patients and proper use of these patches in order to ensure as much as possible the therapeutic efficacy of this new treatment option.Keywords: neuropathic pain, lidocaine, patch
format	article
author	Guy Hans Dominique Robert Johanna Verhulst et al
author_facet	Guy Hans Dominique Robert Johanna Verhulst et al
author_sort	Guy Hans
title	Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
title_short	Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
title_full	Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
title_fullStr	Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
title_full_unstemmed	Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
title_sort	lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
publisher	Dove Medical Press
publishDate	2010
url	https://doaj.org/article/20d456d711354677afaf1faa87794520
work_keys_str_mv	AT guyhans lidocaine5patchforlocalizedneuropathicpainprogressforthepatientanewapproachforthephysician AT dominiquerobert lidocaine5patchforlocalizedneuropathicpainprogressforthepatientanewapproachforthephysician AT johannaverhulst lidocaine5patchforlocalizedneuropathicpainprogressforthepatientanewapproachforthephysician AT etal lidocaine5patchforlocalizedneuropathicpainprogressforthepatientanewapproachforthephysician
_version_	1718403370682679296

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician

Ejemplares similares